跳至主要内容
临床试验/NL-OMON47582
NL-OMON47582招募中2 期

Mesenchymal stem cells for angiogenesis and neovascularisation in digital ulcers of systemic sclerosis - MANUS Trial

niversitair Medisch Centrum Utrecht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Age >18 years
  • - Established diagnosis of SSc according to criteria of the American College
  • of Rheumatology (2013)
  • - At least one active digital ulcer (painful area, >2 mm in diameter with
  • visible depth and loss of dermis) refractory to 5 days intravenous
  • prostacyclines
  • *Refractory to prostacyclins* is defined as
  • * - Worsening of ulcer(s) within 1 month after prostacyclins iv
  • * - No improvement of ulcer(s) after 2 months after prostacyclins iv, as judged
  • by the referring physician
  • * - Recurrence of exactly the same ulcer(s) (same location) within 3 months
  • after prostacyclins iv, - Written informed consent

排除标准

  • - Ulcer with underlying calcinosis (ruled out by X-ray prior to
  • screening/inclusion)
  • - History of neoplasm or malignancy in the past 10 years
  • - Pregnancy or unwillingness to use adequate contraception during study
  • - Serious known concomitant disease with life expectancy <1 year
  • - Uncontrolled hypertension
  • - Uncontrolled acute or chronic infection
  • - Follow-up impossible

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验